为分支链氨基酸在神经病理中的使用奠定了基础:单次口服剂量是否能提供数小时的系统水平升高?
Ezek Mathew1, Nathan Jones1, McKinley Dews1
1Department of Microbiology and Immunology, The University of North Texas Health Science Center, 3500 Camp Bowie Blvd, Fort Worth, TX 76107, USA.
Diseases (Basel, Switzerland)
|March 26, 2025
概括
一次剂量的分支链氨基酸补充剂可显著提高健康成年人的血水平. 这一发现支持口服作为增加分支链氨基酸的可行选择,以获得潜在的治疗益处.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 运动医学 运动医学
背景情况:
- 分支链氨基酸 (BCAA) 具有神经保护性和神经恢复性.
- 建议在接触运动前服用BCAA补充剂,以减轻脑震荡的严重程度.
- 单次口服剂量的非处方BCAA的新陈代谢仍未得到充分研究.
研究的目的:
- 为了阐明专利BCAA产品的单次推剂量的代谢特征.
- 评估口服BCAA补充剂对健康成年人血水平的影响.
主要方法:
- 一个专利的BCAA产品的分析.
- 10名健康成年参与者的代谢评估.
- 在定义的时间点测量血BCAA水平.
主要成果:
- 与基线相比,血BCAA水平在测量时间点内仍然显著升高.
- 一次口服剂量有效地增加了BCAA的血度.
- 口服是提高BCAA水平的可行策略.
结论:
- 口服BCAA补充剂可以维持血水平的升高.
- 这些发现有助于制定有针对性的BCAA剂量策略.
- 潜在的应用包括治疗脑损伤和其他病理.
相关概念视频
Drug Delivery: Parenteral Route
353
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
353
The Blood-brain Barrier
46.4K
Overview
46.4K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
206
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
206
Drugs Affecting Neurotransmitter Synthesis
1.2K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.2K
Local Anesthetics: Adverse Effects
378
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
378


